9:30—10:45 AM ET / 2:30-3:45 PM GMT

The Road to “Gavi 6.0”: A New Strategy for a Changing World


Orin Levine, Non-Resident Fellow, Center for Global Development


  • Johannes Ahrendts, Director, Strategy, Funding and Performance, Gavi, the Vaccine Alliance
  • Gabriella Fésüs, Head of Unit for Social Inclusion & Protection, Health and Demography, Directorate-General for International Partnerships, European Commission
  • Shanelle Hall, Founder, The Yellow House
  • Justice Nonvignon, Head, Health Economics Programme, Africa Centres for Disease Control and Prevention; Non-Resident Fellow, Center for Global Development
  • Kate O’Brien, Director, Department of Immunization, Vaccines and Biologicals, World Health Organization


Janeen Madan Keller, Deputy Director of Global Health Policy and Policy Fellow, Center for Global Development

2024 is a pivotal year for Gavi, the Vaccine Alliance as it formulates a new strategy to inform its next investment case and replenishment cycle—and a new CEO takes the helm. 

Gavi has made significant progress in expanding access to immunization and averting millions of deaths from vaccine-preventable diseases. But disruptions on the horizon are exerting pressure on its ability to deliver results in a rapidly shifting global landscape. The 2026-2030 strategic period, known as  “Gavi 6.0,” offers a critical window to leverage Gavi’s strengths and mitigate impacts of disruptions.

Join CGD for a virtual discussion, building on new research and analyses, to examine how Gavi can adopt a new playbook to maximize impact and remain fit-for-purpose in an evolving global landscape.

Subscribe today to receive CGD’s latest newsletters and topic updates.